Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biocept Inc (BIOC)

Biocept Inc (BIOC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biocept to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27, 2020

, /PRNewswire/ -- . (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients...

BIOC : 0.4980 (-1.39%)
Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector™ BRAF Kit for Clients' Use in Their Own Laboratories

, /PRNewswire/ -- . (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients...

BIOC : 0.4980 (-1.39%)
Biocept Reports First Quarter 2020 Financial Results

, /PRNewswire/ -- (NASDAQ: BIOC), a leading provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Liquid Biopsy Industry Outlook 2020-2030 by Product, End-user, Clinical Application, Region, Country

, /PRNewswire/ -- The report has been added to offering.

BIOC : 0.4980 (-1.39%)
MYGN : 14.27 (-3.16%)
QGEN : 43.26 (+0.63%)
Biocept to Release First Quarter 2020 Financial Results and Host Investor Conference Call on May 13, 2020

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Biocept Announces CE-IVD Mark and Availability of its Target Selector(TM) EGFR Molecular Assay Kit in Europe

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Biocept Announces Pricing of $10.3 Million Registered Direct Offering Priced At-The-Market

Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes...

BIOC : 0.4980 (-1.39%)
Biocept to Begin COVID-19 Testing

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Brazil Patent Granted for Biocept's Target Selector(TM) Oncogene Mutation Enrichment and Detection Platform

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Australia Patent Issued for Primer-Switch Mutation Detection and Amplification Platform

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Biocept Enters into Laboratory Services Agreement with Second California-Based Independent Physician Association

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Biocept Reports 2019 Fourth Quarter and Full Year Financial Results

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports...

BIOC : 0.4980 (-1.39%)
Biocept, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Biocept, Inc. (NASDAQ:BIOC) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 4:30 PM Eastern...

BIOC : 0.4980 (-1.39%)
Biocept, Inc. Discusses Highlights for 2019, Recent News and What to Look Out For in Q2 2020 in New SNNLive Video Interview on SNN Network

LOS ANGELES, CA / ACCESSWIRE / March 18, 2020 / , The Official MicroCap News Source™, today published an SNNLive Video Interview with Mike Nall, CEO of Biocept, Inc. (NASDAQ:BIOC), a leading commercial...

BIOC : 0.4980 (-1.39%)
Biocept to Release 2019 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 25, 2020

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Newly Published Data in Journal of Clinical Pathology Provides Clinical Validation for Biocept's Target Selector(TM) qPCR Assay to Identify Cancer-Associated Mutations

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)
Biocept Announces Pricing of $6.6 Million Registered Direct Offering Priced At-The-Market

Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes...

BIOC : 0.4980 (-1.39%)
Biocept Announces Pricing of $9.2 Million Registered Direct Offering Priced At-The-Market

Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes...

BIOC : 0.4980 (-1.39%)
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with...

BIOC : 0.4980 (-1.39%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.22 , SEDG +6.15 , THC +0.93 , TER +2.10 , LITE +0.93
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar